SLXN
Silexion Therapeutics Corp Ordinary Shares
SLXN
SLXN
8 hedge funds and large institutions have $258K invested in Silexion Therapeutics Corp Ordinary Shares in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$29.5K |
| 2 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$16.2K |
| 3 |
VF
Virtu Financial
New York
|
+$12K |
| 4 |
SG
StoneX Group
New York
|
+$9.11K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WCM
1
Wildcat Capital Management
New York
| $91.9K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $88.5K | +$29.5K | +2,426 | +50% |
|
|
MHC
3
Meyer Handelman Company
Rye Brook,
New York
| $26.7K | – | – | – |
|
|
MSAM
4
Moloney Securities Asset Management
Manchester,
Missouri
| $16.2K | +$16.2K | +1,333 | New |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $13.3K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| $12K | +$12K | +951 | New |
|
|
SG
7
StoneX Group
New York
| $9.11K | +$9.11K | +749 | New |
|
8
Bank of America
Charlotte,
North Carolina
| $405 | – | – | – |
|